| Financial Year |
March 31 2022 |
| Monetary Funds |
13,602,160.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
380,000.00 |
| Accounts Receivable |
48,880,255.12 |
| Advances to Suppliers |
2,850,619.96 |
| Other Receivables |
30,614,255.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,012,218.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,666,833.13 |
| Total Current Assets |
116,006,341.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
41,255,387.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,748,270.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
66,210,071.33 |
| Total Assets |
182,216,412.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
36,858,242.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,997,834.58 |
| Taxes Payable |
3,623,537.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
206,527,208.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,861,901.27 |
| Other Current Liabilities |
738,651.23 |
| Sub-Total of Current Liabilities |
300,954,697.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,354,500.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,908,284.53 |
| Total Liabilities |
370,862,982.05 |
| Paid-In Capital(Or Share Stock) |
873,370,000.00 |
| Capital Surplus |
1,083,997,337.88 |
| Surplus Reserve |
108,587,124.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,997,463,788.83 |
| Minority Stockholder's Interest |
2,013,273.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-190,659,843.18 |
| Owner's Equity（Stockholder's Equity） |
-188,646,569.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
182,216,412.79 |
